By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


OncoCyte Corporation 

1301 Harbor Bay Parkway

Alameda  California  94502  U.S.A.
Phone: 510-521-3390 Fax: 510-521-3389



Company News
BioTime (BTX)’s Subsidiary OncoCyte Corporation Files Form 10 Registration Statement For Planned Distribution 10/8/2015 11:53:12 AM
BioTime (BTX) Subsidiary OncoCyte Corporation Appoints Cavan Redmond To Its Board Of Directors 9/14/2015 12:20:56 PM
The Wistar Institute And BioTime (BTX) Subsidiary OncoCyte Corporation Expand Agreement To Develop Molecular Diagnostic Test For The Detection Of Lung Cancer 8/18/2015 11:17:30 AM
OncoCyte Corporation Announces Appointment Of Andy Arno To Board Of Directors 7/15/2015 10:39:03 AM
William Annett Named Chief Executive Officer Of OncoCyte Corporation 6/16/2015 11:35:39 AM
BioTime (BTX) Release: OncoCyte Corporation’s Collaborators At The Wistar Institute Present Positive Clinical Interim Results Of Blood-Based Diagnostic Test For Non-Invasive Detection Of Lung Cancer 5/19/2015 1:15:03 PM
OncoCyte Corporation Completes Equity Financing Round 5/14/2015 11:14:16 AM
Positive Clinical Results Of OncoCyte Corporation’s Panc-Dx Diagnostic Test Demonstrate High Level Of Sensitivity And Specificity In Non-Invasive Detection Of Bladder Cancer 4/20/2015 1:03:48 PM
OncoCyte Corporation Announces Initial Data From Ongoing Clinical Study Of Collagen Type X As A Marker And Potential Diagnostic For Breast Cancer And Other Types Of Human Cancers 4/20/2015 10:41:13 AM
OncoCyte Corporation Announces Availability Of Abstracts With New Clinical Data From Studies Of Panc-Dx Cancer Diagnostic In Bladder And Breast Cancer 3/20/2015 10:00:34 AM